2026 CPHI Milan Exhibition | Gutuo has been deeply cultivating polypeptide field

6-8 October 2026, annual event for the global pharmaceutical industry-- CPHI Worldwide Milan Exhibition opened at the Fiera Milano Convention and Exhibition Center in Milan, Italy. As the world's most influential B2B platform for pharmaceutical raw materials and pharmaceutical technology, this exhibition brings together more than 2,000 pharmaceutical enterprises, CDMO and biotechnology companies from 166 countries to discuss the innovation trends and development opportunities in the fields of global polypeptide, API and pharmaceutical supply chain. The exhibition has been successfully held for more than 30 sessions so far, attracting many of the world's leading pharmaceutical companies, investment institutions and industry partners. During the exhibition, a series of cooperation and exchange activities have been held, which has become an annual event not to be missed by practitioners in the global pharmaceutical industry.

Hangzhou Gutuo Biotechnology Co., Ltd. (GO TOP PEPTIDE) brought new products and new technologies of polypeptide raw materials to booth 4K56 to communicate face-to-face with European and global customers and expand new opportunities for international cooperation.

During the exhibition, GOTOP Biology (GO TOP PEPTIDE) brought business and technical teams to receive a large number of industry customers from Europe, Asia, North America and other regions at the booth. It mainly conducted in-depth exchanges on topics such as large-scale production of GLP-1 polypeptides from kilogram to ton, development of complex sequence processes, impurity control, matching of regulatory data, and long-term stable supply chain guarantee. The European market has a strong demand for high-quality polypeptide raw materials and CDMO services that can be stably and reliably supplied for a long time. Many visiting customers focus on understanding the industrial production process, production capacity scale, delivery cycle and compliance document support capacity of polypeptide, and fully exchange views on cross-border supply chain cooperation and industrialization landing.